Cornerstone Capital Management Holdings’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.29M | Buy |
15,089
+321
| +2% | +$27.4K | 0.01% | 857 |
|
|
2017
Q3 | $1.25M | Buy |
14,768
+320
| +2% | +$27.2K | 0.01% | 881 |
|
|
2017
Q2 | $1.09M | Sell |
14,448
-1,103
| -7% | -$83.4K | 0.01% | 887 |
|
|
2017
Q1 | $1.03M | Buy |
15,551
+10,147
| +188% | +$669K | 0.01% | 924 |
|
|
2016
Q4 | $341K | Sell |
5,404
-801
| -13% | -$50.5K | ﹤0.01% | 1138 |
|
|
2016
Q3 | $394K | Buy |
6,205
+2,244
| +57% | +$142K | ﹤0.01% | 1108 |
|
|
2016
Q2 | $295K | Buy |
3,961
+1,122
| +40% | +$83.6K | ﹤0.01% | 1132 |
|
|
2016
Q1 | $190K | Sell |
2,839
-962
| -25% | -$64.4K | ﹤0.01% | 1214 |
|
|
2015
Q4 | $257K | Buy |
3,801
+1,717
| +82% | +$116K | ﹤0.01% | 1164 |
|
|
2015
Q3 | $111K | Hold |
2,084
| – | – | ﹤0.01% | 1321 |
|
|
2015
Q2 | $131K | Buy |
2,084
+1,122
| +117% | +$70.5K | ﹤0.01% | 1269 |
|
|
2015
Q1 | $46K | Hold |
962
| – | – | ﹤0.01% | 1313 |
|
|
2014
Q4 | $32K | Buy |
962
+321
| +50% | +$10.7K | ﹤0.01% | 1220 |
|
|
2014
Q3 | $19K | Buy |
+641
| New | +$19K | ﹤0.01% | 1241 |
|